The Center is looking for legal advice on a proposed rule that would impose limitations on how e-pharmacies operate.
According to a news outlet, the ministry of chemicals and fertilisers has drafted draught regulations to prevent online drug sales by e-pharmacies. The hazards associated with a health record data breach and improper usage of internet pharmacies have worried the authorities.
Two illustrious companies that support internet pharmacy that may be impacted by the legislation are The Tatas and Reliance Industries.
The purchase of a majority share in 1MG was announced by Tata Digital, the company that houses the group’s digital assets, in 2021. According to estimates from last September, Tata Digital led an internal investment round that put the company’s valuation at above $1 billion.
The Delhi High Court had requested the Government to provide a status report on petitions calling for a prohibition on the “illegal” selling of narcotics online earlier this month.
Since the Center’s counsel said that a plan to regulate online pharmacies was under discussion and that additional time was required, the subject will now be heard on May 22.
The court has been considering requests to prohibit the “illegal” selling of pharmaceuticals over the internet and to reject the ministry of health and family welfare’s proposed regulations that would further change the Drugs and Cosmetics Regulations.
The South Chemists and Distributors Association, which filed the petition challenging the ministry’s notification from August 2018, claimed the draught rules were being pushed through in flagrant violation of the law while ignoring the health risks associated with the unregulated sale of medicines online.
Zaheer Ahmed, the petitioner, had requested that the e-pharmacies be held in contempt for continuing to conduct online medication sales in defiance of a High Court ruling prohibiting such activity.
